Analysis of antibody-negative medical students after hepatitis B vaccination in Japan

References

• Trepo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014;384:2053–63. doi:10.1016/S0140-6736(14)60220-8.
   PubMed Web of Science ®Google Scholar
• Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3:383–403. doi:10.1016/S2468-1253(18)30056-6.
   PubMed Web of Science ®Google Scholar
• Tanaka J, Akita T, Ko K, Miura Y, Satake M. Countermeasures against viral hepatitis B and C in Japan: an epidemiological point of view. Hepatol Res. 2019;49:990–1002. doi:10.1111/hepr.13417.
   PubMed Web of Science ®Google Scholar
• Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, Chen DS, Chen HL, Chen PJ, Chien RN, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10:1–98.
   PubMed Web of Science ®Google Scholar
• Fattovich G. Natural history and prognosis of hepatitis B. Semin Liver Dis. 2003;23:47–58. doi:10.1055/s-2003-37590.
   PubMed Web of Science ®Google Scholar
• Poh Z, Goh BB, Chang PE, Tan CK. Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients. Eur J Gastroenterol Hepatol. 2015;27:638–43. doi:10.1097/MEG.0000000000000341.
   PubMed Web of Science ®Google Scholar
• Zuckerman JN, Zuckerman AJ, Symington I, Du W, Williams A, Dickson B, Young MD. Evaluation of a new hepatitis B triple-antigen vaccine in inadequate responders to current vaccines. Hepatology. 2001;34:798–802. doi:10.1053/jhep.2001.27564.
   PubMed Web of Science ®Google Scholar
• Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine. 2008;26:6266–73. doi:10.1016/j.vaccine.2008.09.056.
   PubMed Web of Science ®Google Scholar
• Yotsuyanagi H, Takano T, Tanaka M, Amano K, Imamura M, Ogawa K, Yasunaka T, Yasui Y, Hayashi K, Tanaka Y, et al. Hepatitis B virus-related hepatocellular carcinoma in young adults efficacy of nationwide selective vaccination. Hepatol Res. 2019. doi:10.1111/hepr.13439.
   Web of Science ®Google Scholar
• Averhoff F, Mahoney F, Coleman P, Schatz G, Hurwitz E, Margolis H. Immunogenicity of hepatitis B vaccines. Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med. 1998;15:1–8. doi:10.1016/S0749-3797(98)00003-8.
   PubMed Web of Science ®Google Scholar
• Png E, Thalamuthu A, Ong RT, Snippe H, Boland GJ, Seielstad M. A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region. Hum Mol Genet. 2011;20:3893–98. doi:10.1093/hmg/ddr302.
   PubMed Web of Science ®Google Scholar
• Gara N, Abdalla A, Rivera E, Zhao X, Werner JM, Liang TJ, Hoofnagle JH, Rehermann B, Ghany MG. Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults. Clin Infect Dis. 2015;60:505–13. doi:10.1093/cid/ciu867.
   PubMed Web of Science ®Google Scholar
• Sjogren MH. Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccination. Am J Med. 2005;118:34s–39s. doi:10.1016/j.amjmed.2005.07.012.
   PubMed Web of Science ®Google Scholar
• Pharmaceuticals and Medical Devices Agency. Interview form of Heptavax-II (In Japanese). [accessed 2019 Dec 20]. https://www.info.pmda.go.jp/go/interview/2/170050_6313402A2045_2_020_1F.pdf.
   Google Scholar
• Pharmaceuticals and Medical Devices Agency (PMDA). Interview form of Bimmugen (In Japanese). [accessed 2019 Dec 20]. https://www.info.pmda.go.jp/go/interview/2/170050_6313402A2045_2_020_1F.pdf.
   Google Scholar
• Schillie S, Murphy TV, Sawyer M, Ly K, Hughes E, Jiles R, de Perio MA, Reilly M, Byrd K, Ward JW. CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recomm Rep. 2013;62:1–19.
   PubMed Web of Science ®Google Scholar
• Wang ZZ, Gao YH, Wang P, Wei L, Xie CP, Yang ZX, Lan J, Fang ZL, Zeng Y, Yan L, et al. Comparison of immunogenicity between hepatitis B vaccines with different dosages and schedules among health young adults in China: a 2-year follow-up study. Hum Vaccin Immunother. 2018;14:1475–82. doi:10.1080/21645515.2018.1438090.
   PubMed Web of Science ®Google Scholar
• Struve J, Aronsson B, Frenning B, Granath F, Sydow MV, Weiland O. Intramuscular versus intradermal administration of a recombinant hepatitis B vaccine: a comparison of response rates and analysis of factors influencing the antibody response. Scand J Infect Dis. 1992;24:423–29. doi:10.3109/00365549209052627.
   PubMed Web of Science ®Google Scholar
• Wahl M, Hermodsson S. Intradermal, subcutaneous or intramuscular administration of hepatitis B vaccine: side effects and antibody response. Scand J Infect Dis. 1987;19:617–21. doi:10.3109/00365548709117195.
   PubMed Web of Science ®Google Scholar
• Liu F, Guo Z, Dong C. Influences of obesity on the immunogenicity of hepatitis B vaccine. Hum Vaccin Immunother. 2017;13:1014–17. doi:10.1080/21645515.2016.1274475.
   PubMed Web of Science ®Google Scholar
• Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis. 2011;53:68–75. doi:10.1093/cid/cir270.
   PubMed Web of Science ®Google Scholar
• Höhler T, Stradmann-Bellinghausen B, Starke R, Sänger R, Victor A, Rittner C, Schneider PM. C4A deficiency and nonresponse to hepatitis B vaccination. J Hepatol. 2002;37:387–92. doi:10.1016/S0168-8278(02)00205-2.
   PubMed Web of Science ®Google Scholar
• Ryckman KK, Fielding K, Hill AV, Mendy M, Rayco-Solon P, Sirugo G, van der Sande MA, Waight P, Whittle HC, Hall AJ, et al. Host genetic factors and vaccine-induced immunity to HBV infection: haplotype analysis. PLoS One. 2010;5:e12273. doi:10.1371/journal.pone.0012273.
   PubMed Web of Science ®Google Scholar
• Davila S, Froeling FE, Tan A, Bonnard C, Boland GJ, Snippe H, Hibberd ML, Seielstad M. New genetic associations detected in a host response study to hepatitis B vaccine. Genes Immun. 2010;11:232–38. doi:10.1038/gene.2010.1.
   PubMed Web of Science ®Google Scholar